10-Q: Quarta-Rad Shifts to AI Amidst Going Concern Doubts

Quarta-Rad, Inc. reported continued operating losses and a significant strategic pivot towards AI-driven call center software, while facing substantial doubt about its ability to continue as a going concern.

Summary

• Quarta-Rad, Inc. reported a net loss of $149,504 for the six months ended June 30, 2025, a slight decrease from $153,995 in the prior year period.
• Total net revenues increased by 96.17% to $100,217 for the six months ended June 30, 2025, primarily driven by the Sellavir segment.
• The traditional Quarta-Rad segment's net revenues significantly decreased by 89.79% to $5,217 for the six months ended June 30, 2025, compared to $51,086 in the prior year.
• Sellavir, the AI subsidiary, generated $95,000 in revenue for the six months ended June 30, 2025, compared to zero in the prior year, as it began recognizing revenue in September 2024.
• Cash decreased to $29,563 as of June 30, 2025, from $63,021 at December 31, 2024.
• The company continues to experience recurring operating losses, raising substantial doubt about its ability to continue as a going concern, with current operations funded by the shareholder.
• Material weaknesses in internal controls over financial reporting were identified, including inadequate segregation of duties and insufficient technical accounting knowledge.

Sentiment

Score: 2

Explanation: The company faces severe going concern risks due to recurring losses and declining cash. While the pivot to AI shows potential, it is early stage and unproven, and significant internal control weaknesses are a major concern. The reliance on related-party funding and transactions adds to the risk profile.

Positives

• Total net revenues increased by 96.17% for the six months ended June 30, 2025, driven by the new Sellavir AI segment.
• Sellavir, the AI-focused subsidiary, successfully began recognizing revenue, contributing $95,000 in sales for the six-month period.
• The consolidated net loss slightly decreased by 2.92% for the six months ended June 30, 2025, compared to the prior year.
• Cash used in operating activities slightly decreased to $33,458 for the six months ended June 30, 2025, from $34,413 in the prior year, indicating a minor improvement in operational cash burn.

Negatives

• The company continues to experience recurring operating losses, with a net loss of $149,504 for the six months ended June 30, 2025.
• The traditional Quarta-Rad segment's net revenues plummeted by 89.79% to $5,217 for the six months ended June 30, 2025, indicating a severe decline in its core business.
• Cash on hand significantly decreased to $29,563 as of June 30, 2025, from $63,021 at December 31, 2024.
• The company's current financial condition and recurring losses raise substantial doubt about its ability to continue as a going concern.
• Sellavir stopped recognizing accrued interest income on a related-party note receivable as of March 31, 2025.
• Operating expenses increased by 33.93% for the six months ended June 30, 2025, primarily due to stock-based compensation from Sellavir.

Risks

• Recurring operating losses and limited revenues raise substantial doubt about the company's ability to continue as a going concern.
• The success of the new call center product, CenterEye, depends on the company's ability to develop features, keep up with technological advancements, and address software bugs or security vulnerabilities promptly, with no guarantee of market acceptance.
• The company has encountered restrictions in securing inventory for its Quarta-Rad segment due to the Russian invasion of Ukraine and related sanctions, impacting its ability to purchase from previous suppliers.
• Material weaknesses exist in internal controls over financial reporting, including inadequate segregation of duties, insufficient technical accounting knowledge, lack of risk assessment, and inadequate entity-level and system/manual controls.
• Reliance on a single Japanese reseller for Sellavir's sole revenue stream in the consulting business poses a concentration risk.
• Notes receivable from a related Thai Corporation have deferred payments until April 2027 and April 2026, with interest payable at the end of the loan, and interest recognition was paused on one note.

Future Outlook

The company is strategically shifting its primary focus from Geiger counter sales to the development and marketing of CenterEye, its proprietary AI-driven call center software. It aims to enhance call center efficiency and customer engagement through innovative AI solutions, actively pursuing sales opportunities in the U.S., Japan, and other international markets, with recent traction noted in Japan. The company intends to continue investing in software development, marketing (estimated cost $25,000-$75,000), and establishing partnerships with call center operators and technology resellers (estimated cost $20,000). There are also plans to explore distributing current operations in a spin-off.

Management Comments

• Management believes that the disclosures are adequate to make the information presented not misleading.
• Management intends to maintain adequate working capital and adhere to prudent financial forecasting to address going concern considerations.
• Management believes that the identified material weaknesses in internal controls did not impact financial reporting or result in a material misstatement of the condensed financial statements.
• Management does not anticipate the need to hire additional full or part-time employees over the next three months, as services provided by officers, directors, and independent contractors are deemed sufficient.

Industry Context

The company's strategic pivot towards AI-driven call center software aligns with broader industry trends emphasizing digital transformation, automation, and enhanced customer experience through artificial intelligence. The shift from traditional on-premise solutions to cloud-hosted platforms in the call center industry presents a significant market opportunity for AI-driven products like CenterEye. This move positions the company to capitalize on the growing demand for advanced analytics and AI technologies in customer service, moving away from its declining legacy business of radiation detection device distribution.

Management Changes

Corporate Governance

Related Party Transactions

• Sellavir entered into two loan agreements with a related Thai Corporation (where the company's CEO is a minority shareholder). The first loan, originally $261,038, was amended to reduce interest and defer payments until April 1, 2027. The second loan, originally $175,000, was also amended to reduce interest and defer payments until April 1, 2026, and was subsequently assigned to the company's CEO in March 2025 to satisfy $164,375 of expenses and $35,000 of accrued salary.
• Sellavir stopped recognizing accrued interest income on the first note receivable from the Thai Corporation as of March 31, 2025.
• The company owes Star Systems Corporation (owned by the company's majority shareholder) $42,502 for inventory and upgrades from 2022, due on demand without interest.
• The company owes a Russian affiliate $91,850 for software development from a contract that ended in December 2019, due on demand without interest.
• The company compensates its CEO (majority shareholder) $8,000 per quarter, with accrued compensation of $101,000 as of June 30, 2025.
• The CEO advanced funds for operations and is owed $12,780 as of June 30, 2025, due on demand without interest.
• Sellavir recognized $95,000 in revenue for the six months ended June 30, 2025, from contract services to STAR, which is owned by the CEO of Quarta-Rad.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern issues, recurring losses, and the uncertainty of the new AI business's success. The high volume of related-party transactions and internal control weaknesses also pose governance and transparency concerns.
• Employees (primarily officers and independent contractors) are currently sufficient for the small-scale operations, but future growth and stability are uncertain given the financial challenges.
• Customers of the traditional Quarta-Rad segment may experience reduced product availability due to supply chain restrictions and the company's shift in focus.
• Customers of the new Sellavir CenterEye platform may benefit from innovative AI solutions, but the success and long-term viability of the product are unproven.
• Creditors, particularly the CEO and related parties, are exposed to the company's financial instability, with some related-party notes having deferred payment terms and paused interest recognition.

Next Steps

• Continue to invest in the development and enhancement of CenterEye software, including adding new features, improving user experience, and ensuring scalability.
• Increase marketing efforts for CenterEye on the Internet and through brochures/materials to industry professionals, with estimated costs of $25,000-$75,000.
• Establish partnerships with call center operators and technology resellers, and secure pilot projects and initial deployments for CenterEye, with estimated costs of $20,000.
• Purchase inventory to increase sales for the Quarta-Rad segment, with the amount directly related to demand.
• Remediate identified material weaknesses in internal controls by enhancing training and oversight of accounting personnel and engaging an independent consultant with expertise in income tax and complex U.S. GAAP matters.
• Explore plans to distribute current operations (Quarta-Rad and Sellavir) in a spin-off.

Key Dates

Recommendation

The company faces severe fundamental challenges, including recurring operating losses, a significant going concern doubt, and a rapidly declining legacy business. While the pivot to AI through Sellavir offers a potential growth avenue, it is nascent, unproven, and currently operating at a loss. The identified material weaknesses in internal controls over financial reporting are a critical red flag, indicating potential issues with financial integrity and operational oversight. Furthermore, the extensive related-party transactions, including deferred loan payments and paused interest recognition, raise concerns about transparency and potential conflicts of interest. The substantial decrease in cash on hand exacerbates liquidity risks. For a seasoned investor, these combined factors present an extremely high-risk profile with limited near-term catalysts for positive change, warranting a strong sell recommendation.

Keywords

AI, Artificial Intelligence, Call Center Software, CenterEye, Geiger Counter, Radiation Detection, SEC Filing, 10-Q, Financial Reporting, Going Concern, Software Development, Corporate Governance, Related Party Transactions